statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business PR Newswire...

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Labcorp acquires certain operations of Opko Health subsidiary BioReference Health. The assets Labcorp is acquiring generate about $100 million in annual revenue, with the transaction valued at $237.5...

Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Health

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Opko Health's ModeX presents results from Phase 1 study of SAR441236

Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans Candidate showed similar half-life to standard monoclonal...

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on...

NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st

Opko Health reports Q4 EPS (9c), consensus (10c)

OPKO Health: Q4 Earnings Insights

Conference call begins at 4:30 p.m. Eastern time todayMIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12...

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

MIAMI, Feb. 22, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2023 after the close of the...

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

Opko Health Inc (OPK) has released an update to notify the public and investors about its officers. Alexis Borisy, a board and compensation committ...

Opko Health Board Member Alexis Borisy to Depart

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Watchers	28,327
52-Wk Low	$0.8516
52-Wk High	$2.24

Volume	1.5M
52-Wk High	$2.24
52-Wk Low	$0.8516

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.10	--	--	N/A
Q1'24	-$0.10	-$0.12	-25.85%	MISSED
Q4'23	-$0.10	-$0.09	10.00%	BEAT
Q3'23	-$0.10	-$0.11	-10.00%	MISSED
Q2'23	-$0.07	-$0.03	58.14%	BEAT

OPK Opko Health Inc

About

Feed

News

Sentiment

Earnings

Fundamentals